help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cordonnier, C.
Right arrow Articles by Bernaudin, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cordonnier, C.
Right arrow Articles by Bernaudin, J. F.

Am. J. Respir. Crit. Care Med., Vol 149, No. 3, Mar 1994, 788-794.

Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients

C Cordonnier, J Fleury-Feith, E Escudier, K Atassi and JF Bernaudin
Department of Clinical Hematology, Hopital Henri Mondor, Creteil, France.

We report here our experience of secondary pulmonary alveolar proteinosis (PAP) in patients with hematologic malignancies. The diagnosis of PAP was made by bronchoalveolar lavage (BAL) and based on the identification of periodic acid-Schiff-positive proteinaceous material with the characteristic ultrastructural pattern. Ten patients with leukemia and secondary PAP are described. Three patients had received bone marrow transplants. Data obtained from sequential BAL have shown that at least four of them--all of them achieving complete remission or recovery from neutropenia after bone marrow transplantation--had reversible PAP, and we emphasize this potential reversibility. Furthermore, in order to estimate the frequency of PAP in hematologic patients, we retrospectively studied 113 episodes of pneumonia occurring in our department over a 2-yr period. The incidence of secondary PAP in patients with pulmonary symptoms was so estimated at 5.3% among all the hematologic population, and to 10% in patients with myeloid disorders. This report (1) confirms that BAL is an accurate way to diagnose PAP in immunocompromised hosts, (2) emphasizes that PAP is not an unusual cause of respiratory failure in this population and that it is strongly associated with myeloid disorders, and (3) shows that secondary PAP is potentially reversible, especially if complete remission of the underlying disease is achieved.


This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
O C Ioachimescu and M S Kavuru
Pulmonary alveolar proteinosis
Chronic Respiratory Disease, July 1, 2006; 3(3): 149 - 159.
[Abstract] [PDF]


Home page
Eur Respir JHome page
A. Bush
Paediatric interstitial lung disease: not just kid's stuff
Eur. Respir. J., October 1, 2004; 24(4): 521 - 523.
[Full Text] [PDF]


Home page
NEJMHome page
B. C. Trapnell, J. A. Whitsett, and K. Nakata
Pulmonary Alveolar Proteinosis
N. Engl. J. Med., December 25, 2003; 349(26): 2527 - 2539.
[Full Text] [PDF]


Home page
ChestHome page
S.-L. Cheng, P.-H. Kuo, P.-C. Yang, and K.-T. Luh
Bilateral Alveolar Infiltrates in a 29-Year-Old Man With Chronic Myelogenous Leukemia
Chest, December 1, 2002; 122(6): 2238 - 2241.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. F. Seymour and J. J. Presneill
Pulmonary Alveolar Proteinosis: Progress in the First 44 Years
Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 215 - 235.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
I Khurshid and L C Anderson
Non-infectious pulmonary complications after bone marrow transplantation
Postgrad. Med. J., May 1, 2002; 78(919): 257 - 262.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C.-W. Chou, F.-C. Lin, S.-M. Tung, R.-D. Liou, and S.-C. Chang
Diagnosis of Pulmonary Alveolar Proteinosis: Usefulness of Papanicolaou-Stained Smears of Bronchoalveolar Lavage Fluid
Arch Intern Med, February 26, 2001; 161(4): 562 - 566.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C. Mayaud and J. Cadranel
A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host
Thorax, June 1, 2000; 55(6): 511 - 517.
[Full Text]


Home page
ThoraxHome page
P. L Shah, D. Hansell, P. R Lawson, K. B M Reid, and C. Morgan
Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis
Thorax, January 1, 2000; 55(1): 67 - 77.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society